Exploiting Zebrafish Xenografts for Testing the in vivo Antitumorigenic Activity of Microcin E492 Against Human Colorectal Cancer Cells

One of the approaches to address cancer treatment is to develop new drugs not only to obtain compounds with less side effects, but also to have a broader set of alternatives to tackle the resistant forms of this pathology. In this regard, growing evidence supports the use of bacteria-derived peptide...

詳細記述

書誌詳細

主要な著者:	Macarena A. Varas, Carlos Muñoz-Montecinos, Violeta Kallens, Valeska Simon, Miguel L. Allende, Andrés E. Marcoleta, Rosalba Lagos
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2020-03-01
シリーズ:	Frontiers in Microbiology
主題:	microcin E492 antitumorigenic peptide zebrafish xenograft bacteriocin colorectal cancer human cell lines
オンライン･アクセス:	https://www.frontiersin.org/article/10.3389/fmicb.2020.00405/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!